angiotensin converting enzyme 2
Predicting the Angiotensin Converting Enzyme 2 (ACE2) Utilizing Capability as the Receptor of SARS-CoV-2
... hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by ...
13
Autoantibodies to angiotensin converting enzyme 2 in patients with connective tissue diseases
... Detection of anti-ACE2 antibodies in patient serum We established an ELISA using purified recombinant human ACE2. A plasmid DNA-encoding human ACE2 cDNA, which was kindly gifted from Dr Hyeryun Choe (Harvard Medical ...
8
A pilot clinical trial of recombinant human angiotensin converting enzyme 2 in acute respiratory distress syndrome
... Part B of the study was designed to randomize 60 subjects, with planned interim analyses after approximately half the subjects had completed 7 days of follow-up. In the original protocol, the interim analysis in part B ...
9
Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With Proteinuria
... A 24-hour urine collection and a 5-mL blood sample, drawn at the end of the urine collection itself, were obtained at time 0, time 1, and time 2. Urinary and blood concentrations of creatinine, sodium, potassium, ...
8
ASSOCIATION OF ANGIOTENSIN I CONVERTING ENZYME INHIBITORS WITH THE ANGIOTENSIN II RECEPTORS ANTAGONISTS
... A different therapeutic strategy based on the combination of lower doses than recommended of an ACE inhibitor and an ARB has been suggested to effectively block the renin-angiotensin system without excessive ...
5
Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review
... According to the forest plot in figure 2, it is clear that conflicting reports are evident among all of the studies included. In total, five studies showed that ARB had significant advantage over ACEi including ...
5
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
... The demographic characteristics of the patients, includ- ing age, gender, monthly income (,NT$ 19,100, NT$ 19,100–NT$ 41,999, and .NT$ 42,000), hospital level at admission (medical center, regional, district, and ...
8
Case management for patients with chronic systolic heart failure in primary care: The HICMan exploratory randomised controlled trial
... A2RA: Angiotensin-2 receptor antagonist; ACE: Angiotensin converting enzyme; CCCT: Coordination Centre Clinical Trials; CCM: Chronic Care Model; CHD: Coronary heart disease; CHF: ...
14
Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients
... this was cross sectional study conducted in different hospitals and healthcare centers in Khartoum state, Sudan. A total of 120 patients were enrolled in this This study revealed that most of the patients (37.5 %) are ...
5
Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study
... correlation was used to examine the associations be- tween the plasma 2OG measurements (log-transformed) and other laboratory measurements. Tests for linear trend were performed by entering the median value of each ...
9
The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease
... hours, 2 ml of CSF samples were centrifuged at 1,800 × g for 10 minutes at 4°C and stored at −20°C for analysis of CSF biomarkers within 2 months (see ...
10
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
... their baseline characteristics (the propensity score), and (2) the effects of baseline characteristics (covariates) upon the outcome of interest (follow up Hgb). This approach to data analysis is “doubly robust” ...
6
“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.
... by angiotensin- converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs) and blocking Adrenergic beta receptor forms the foundation of the evidence-based therapy ...
5
Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial
... either angiotensin-converting enzyme inhibitors or angiotensin type 1 receptor blockers reduces the incidence of new onset type 2 diabetes in subjects with hypertension and/or ...
8
Patient- and provider-related determinants of generic and specific health-related quality of life of patients with chronic systolic heart failure in primary care: a cross-sectional study
... A2RA: Angiotensin-2 receptor antagonist; ACE: Angiotensin converting enzyme; CCCT: Coordination Centre Clinical Trials; CABG: Coronary artery bypass graft surgery; CHD: Coronary heart ...
11
Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study
... Patients who had their ACEi/ARBs therapy continued peri-operatively did not have a higher incidence of postoperative AKI compared with those who had these drugs withheld (68 (18.1%) vs. 107 (18.7%), respectively; p = ...
10
Primary care based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial
... A2RA: Angiotensin-2 receptor antagonist; ACE: Angi- otensin converting enzyme; CHD: Coronary heart disease; CHF: Chronic (systolic) heart failure; CI: Confidence interval; CME: Continuous ...
16
The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
... ACE: Angiotensin-converting enzyme; ADAM: Disintegrin-metalloproteinase; ALDH2: Aldehyde dehydrogenase 2; AngII: Angiotensin II; Ap1: Activator protein-1; ArKO: Aromatase knockout; ...
16
Memory is preserved in older adults taking AT1 receptor blockers
... ACE: Angiotensin-converting enzyme; ACEI: Angiotensin-converting enzyme inhibitors; ADNI: Alzheimer ’ s Disease Neuroimaging Initiative; ANOVA: Analysis of variance; APOE: ...
14
Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study
... an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-II receptor blocker (ARB) prevents the progression of CKD ...type 2 diabetes mellitus (DM) were termi- nated early ...
12